Alterity Therapeutics Files 6-K, Incorporates Cash Flow Report
Ticker: PRNAF · Form: 6-K · Filed: Jul 30, 2025 · CIK: 1131343
| Field | Detail |
|---|---|
| Company | Alterity Therapeutics Ltd (PRNAF) |
| Form Type | 6-K |
| Filed Date | Jul 30, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing-update, cash-flow, registration-statement
TL;DR
Alterity Therapeutics filed a 6-K with cash flow update, relevant for S-8 and F-3 filings.
AI Summary
Alterity Therapeutics Ltd. filed a Form 6-K on July 30, 2025, incorporating by reference its Quarterly Activities/Appendix 4C Cash Flow Report. This filing is related to its ongoing registration statements on Form S-8 and Form F-3, indicating potential stock issuances or offerings.
Why It Matters
This filing provides an update on Alterity Therapeutics' financial activities and cash flow, which is crucial for investors to assess the company's operational status and funding needs.
Risk Assessment
Risk Level: medium — The filing incorporates a cash flow report and relates to registration statements, suggesting potential equity events that could impact share price.
Key Players & Entities
- Alterity Therapeutics Ltd. (company) — Filer of the 6-K report
- 20250730 (date) — Filing date of the 6-K
- Form S-8 (document) — Registration statement referenced in the filing
- Form F-3 (document) — Registration statement referenced in the filing
- Quarterly Activities/Appendix 4C Cash Flow Report (document) — Report incorporated by reference
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose is to report information as required by Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, specifically incorporating by reference the Quarterly Activities/Appendix 4C Cash Flow Report.
Which registration statements is this 6-K filing being incorporated into?
This 6-K is being incorporated by reference into Alterity Therapeutics' Registration Statements on Form S-8 (Files No. 333-251073, 333-248980, and 333-228671) and Form F-3 (Files No. 333-274816, 333-251647, 333-231417, and 333-250076).
What is the filing date of this Form 6-K?
The filing date of this Form 6-K is July 30, 2025.
What is the name of the company filing this report?
The name of the company filing this report is Alterity Therapeutics Limited.
What specific report is being submitted as an exhibit with this 6-K?
The specific report submitted as an exhibit is the Quarterly Activities/Appendix 4C Cash Flow Report.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 30, 2025 regarding ALTERITY THERAPEUTICS LTD (PRNAF).